Latest News - Galderma

Wednesday, January 23, 2019

Galderma Forms Women In Aesthetics Leadership Council

Galderma Laboratories, L.P. has formed a Women in Aesthetics Leadership Council, comprised of clinicians, clinical trial investigators, CEOs, business owners, and practice managers. "…

Read the full story

Monday, November 05, 2018

FDA Approves Galderma’s Restylane Lyft for Midface Injection Via Cannula

The U.S. Food and Drug Administration (FDA) has approved the use of Galderma’s Restylane Lyft with a small, blunt-tip cannula for cheek augmentation and the correction of age-related midface con…

Read the full story

Thursday, October 25, 2018

Milestone Alert: Galderma’s ASPIRE Rewards Program Hits the Million Member Mark

Galderma Laboratories, L.P’s ASPIRE Rewards program has reached the one million member milestone. ASPIRE is a loyalty program for consumers and aesthetic providers who use Galderma aesthetic …

Read the full story

Thursday, October 11, 2018

Galderma Ups Its Aesthetic R&D Game

Galderma Laboratories, L.P. is initiating six new Phase III and IV U.S. aesthetic clinical trials. The six newly initiated studies include three pivotal trials evaluating XpresHAn Technology p…

Read the full story

Tuesday, September 25, 2018

Celebrity Manicurist Joins with Galderma for "Face Your Hands" Campaign

Galderma Laboratories, L.P.,’s Restylane® Lyft is partnering with celebrity manicurist Deborah Lippmann for the "Face Your Hands" campaign, which aims to educate women on the steps…

Read the full story

Monday, September 24, 2018

Nestle to Explore Strategic Options for Skin Health Division

...After further analysis and consideration, the Board has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group’s strategic…

Read the full story

Tuesday, September 18, 2018

Experts Call for Improved Identification of "High Burden" Rosacea Patients in Everyday Practice

Additional analysis of a global survey conducted and presented earlier this year, as an expert-authored report called Rosacea: Beyond the visible, assists healthcare professionals in identifying the c…

Read the full story

Thursday, July 26, 2018

Survey: Most Women Think Their Hands Make Them Look Old

Just shy of 80 percent of women ages 40 and older wish they could change the way their hands look, according to Nestlé Skin Health’s 'Face Your Hands' survey. Additionally, 60 …

Read the full story

Friday, July 20, 2018

Breaking News: Galderma Skinpact Awards Deadline Extended!

The new deadline for the Galderma Skinpact Awards is July 31, 2018. The awards are a social responsibility program by Galderma International in partnership with the Canadian Dermatology Association…

Read the full story

Wednesday, July 11, 2018

Fourth Generation Retinoid Shows Promise in Acne Trials

New research reveals that trifarotene, a fourth-generation retinoid with potent and selective activity against only one particular retinoic acid receptor, may have an improved efficacy and safety prof…

Read the full story

Friday, June 08, 2018

Galderma Global Survey Assesses Burden of Rosacea

    Recently released findings from Galderma’s global survey on the true burden of rosacea suggest a need for dermatologists and doctors to proactively open a dialogue with patie…

Read the full story

Monday, May 21, 2018

FDA Greenlights Restylane Lyft for Hand Rejuvenation

The US Food and Drug Administration has approved Restylane Lyft for use on the dorsal hands of people older than 21, making it the first hyaluronic acid (HA) injectable gel approved for this…

Read the full story

Monday, April 30, 2018

New Phase 4 Data: Epiduo Forte Gel Decreased Acne Lesions, Reduced Risk of Scars

Results from OSCAR, a Phase 4, multicenter, randomized, investigator-blinded, vehicle-controlled, intra-individual comparison study (right/left half-face), revealed that Epiduo Forte (adapalene a…

Read the full story

Tuesday, March 06, 2018

Differin Launches Retinoid Education Week

Differin® has launched Retinoid Education Week to educate the more than 50 million Americans with acne about how retinoids can be used to treat their condition. Part of Nestlé Skin Health&r…

Read the full story

Friday, February 23, 2018

Galderma Enters into Long-term Research Agreement on AD with Icahn School of Medicine at Mount Sinai and Northwestern University Feinberg School of Medicine

Galderma has signed a joint research agreement on Atopic Dermatitis (AD) with two leading academic institutions -- Icahn School of Medicine at Mount Sinai in New York City, and Northwestern University…

Read the full story
Load More